Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.
- Resource Type
- Source
- Publisher:
Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN:2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE - Subject
- Language
- English
- ISSN
- 2234-943X